Details for Patent: 11,813,435
✉ Email this page to a colleague
Which drugs does patent 11,813,435 protect, and when does it expire?
Patent 11,813,435 protects ZURNAI (AUTOINJECTOR) and XYOSTED (AUTOINJECTOR) and is included in two NDAs.
This patent has thirty-three patent family members in eleven countries.
Drugs Protected by US Patent 11,813,435
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Purdue Pharma Lp | ZURNAI (AUTOINJECTOR) | nalmefene hydrochloride | SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS | 218590-001 | Aug 7, 2024 | RX | Yes | Yes | 11,813,435 | ⤷ Subscribe | Y | ⤷ Subscribe | ||||
Antares Pharma Inc | XYOSTED (AUTOINJECTOR) | testosterone enanthate | SOLUTION;SUBCUTANEOUS | 209863-001 | Sep 28, 2018 | RX | Yes | Yes | 11,813,435 | ⤷ Subscribe | Y | ⤷ Subscribe | ||||
Antares Pharma Inc | XYOSTED (AUTOINJECTOR) | testosterone enanthate | SOLUTION;SUBCUTANEOUS | 209863-002 | Sep 28, 2018 | RX | Yes | Yes | 11,813,435 | ⤷ Subscribe | Y | ⤷ Subscribe | ||||
Antares Pharma Inc | XYOSTED (AUTOINJECTOR) | testosterone enanthate | SOLUTION;SUBCUTANEOUS | 209863-003 | Sep 28, 2018 | RX | Yes | Yes | 11,813,435 | ⤷ Subscribe | Y | ⤷ Subscribe | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 11,813,435
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Australia | 2013203784 | ⤷ Subscribe | |||
Canada | 2868500 | ⤷ Subscribe | |||
Canada | 2900672 | ⤷ Subscribe | |||
China | 104487114 | ⤷ Subscribe | |||
Denmark | 2953667 | ⤷ Subscribe | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |